The Women’s Clinic 婦產科中心 Current Criticism on IVM Treatment Dr. Milton Leong MDCM DSc (McGill) Director, IVF Center, Hong Kong Sanatorium & Hospital Specialist.

Slides:



Advertisements
Similar presentations
In Vitro Fertilization
Advertisements

M ITOCHONDRIAL GENOME REPLACEMENT IN UNFERTILIZED OOCYTES FOR TREATMENT OF INHERITED MT DNA DISEASE Shoukhrat Mitalipov 1.
New Developments in Assisted Reproduction
The Debate: Fresh vs Frozen Transfer The Cold, Hard Truth
PREVENTION OF MULTIPLES FROM A CLINICIAN’S STANDPOINT Bulent Urman M.D. American Hospital of Istanbul.
ART-IVF: the Long and Short of it Professor Ernest Hung Yu NG Department of Obstetrics & Gynaecology The University of Hong Kong.
Elonva in poor responders
Hananel Holzer, MD Medical Director, MUHC Reproductive Center McGill University Health Center Director, REI Division, Dept. of Obstetrics & Gynecology.
Minimal Monitoring of Ovulation Induction (OI) Is It Safe? Mustafa Uğur Zekai Tahir Burak Women’s Health Education and Research Hospital, Ankara, Turkey.
But it still needs a bit of work. Reprogenetics ART Institute of Washington Life Global Principle investigator of cytoplasmic transfer.
The Latest and Greatest on Egg Freezing
INDIVIDUALIZED IVF TREATMENT
History and Fundamentals of Oocyte Maturation in Vitro
1 Genomic Medicine of the Future UTERINE LAVAGE IN VIVO FERTILIZATION PGD/PGS WITHOUT IVF John E. Buster, M.D., Professor Obstetrics and Gynecology, Warren.
OVARIAN STIMULATION: WHEN DOES LESS ACHIEVE MORE? Milton K.H. Leong, M.D. IVF Centre Hong Kong Sanatorium & Hospital, China Overview and Introduction.
The Women’s Clinic 婦產科中心 New Concept of Controlled Ovarian Stimulation in IVF Dr. Milton Leong MDCM DSc (McGill) Director, IVF Center, HKSH Specialist.
Fertility Diagnosis and Therapy 2008 Gad Lavy, M.D. New England Fertility Institute Lifeline Cryogenics.
The Effect of PCOS Treatment on Ovarian Function
In vitro maturation of oocytes as a promising treatment option for infertile couples: a transdisciplinary study Beum Soo An, Junling Chen Xi-Kuan Chen,
SURGICAL TREATMENT OF PCOS SURGICAL TREATMENT OF PCOS Professor T C LI Professor of Reproductive Medicine & Surgery Sheffield.
TEMPLATE DESIGN © Laparoscopic Ovarian Drilling For Polycystic Ovary Syndrome(PCOS) – Are We Wasting Women’s Time? Chima.
Role of Anti-Mullerian hormone in prediction of Assisted Reproductive Technology outcomes Leili Safdarian M.D. Khadigeh Khosravi M.D. Marzieh Agha Hosseini.
Insulin sensitizing agents use in pregnancy and as therapy in PCOS
IVM is ready as a treatment for PCOS patients
Fertility issues for patients with lymphoma
PHYSICIAN FLIP CHART. Ottawa Fertility Centre The Egg Donation Process.
The outcome of oocyte freezing as compared with embryo freezing Filippo Maria Ubaldi M.D. M.Sc. CLINICA VALLE GIULIA, Rome 3° Congress of Society of Reproductive.
Selective Single Embryo Transfers: A Preliminary Study L. Keith Smith, Ellen H. Roots and M. Janelle Odom Dorsett The Centre for Reproductive Medicine,
Safety and efficacy of FSH drugs in ART for polycystic ovarian disease M. Aboulghar Cairo, Egypt.
THE IMPACT OF FEMALE OBESITY ON IN VITRO FERTILIZATION OUTCOMES Prof. Dr. İdris KOÇAK ONDOKUZ MAYIS UNIVERSITY DEPARTMENT OF OBSTETRICS AND GYNECOLOGY,
Objectives Polycystic ovary syndrome (PCOS) is characterized by chronic anovulation and hyperandrogenism and affects approximately 5–10% of women of reproductive.
Hong Kong Sanatorium & Hospital, China
TEMPLATE DESIGN © Oocyte donation outcomes at Alpha International Fertility Centre IntroductionResultsConclusions References.
Planning of GnRH antagonist cycles
Microinjection and Fallopian Transfer (MIFT) - an effective form of Assisted Reproductive Technology(ART) for the treatment of severe male infertility.
More Than 60 Published Studies In Medical Literature SMOKING & REPRODUCTION.
Treatment Options for Infertility
CONCEPTION, DEVELOPMENT, AND BIRTH CHAPTER 46 (AP BOOK)
Hakan Özörnek EUROFERTIL IVF Center Turkey.  No or minimal stimulation  Low cost  Less monitoring  Less side effects (OHSS)  Acceptable pregnancy.
The Women ’ s Clinic 婦產科中心 IVM/IVF in PCOS (PCO-Like Ovaries) Milton Ka Hong Leong MDCM DSc(McGill) FRCS(C) FRCOG FACOG FHKCOG Director, IVF Centre HK.
Dr. Milton Leong Director
Embryo development Day 0 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6.
The Effect of Bromocriptine-Rebound Method on Ongoing Pregnancy and Live Birth after Intracytoplasmic Sperm Injection Cycles: a Randomized Clinical Trial.
The 4th Misurata scientific meeting of infertility Benghazi – Libya 10/10/2008 Dr. Omar A. Elsraiti Consultant of Obst. & Gyn. IVF Centre - Misurata /
GNRH-A TRIGGER AND INDIVIDUALIZED LUTEAL PHASE HCG SUPPORT WILL AVOID OHSS IN PCOS PATIENTS. Shahar Kol, IVF Unit Rambam Health Care Campus, and Faculty.
Agonist vs Antagonist Dr. Milton Leong.
Recommended Dosage of GnRH Antagonist is Too High Presented by Dr. Milton Leong, MD DSc(McGill) Director, IVF Centre.
Increased risk of pregnancy-induced hypertension in young recipients of donated oocytes Debbra A. Keegan, M.D., Lewis C. Krey, Ph.D., Hung-Chi Chang, M.D.,
Endometrial scratching performed in the non-transfer cycle and outcome of assisted reproduction: a randomized controlled trial CO Nastri, RA Ferriani,
Results 13 papers Heterogeneity of morphokinetic and conditions (culture media, mode of fertilization, day of ET)
Methods of assisted reproduction MUDr.Jitka Řezáčová ÚPMD, Praha 4, Podolí.
Selecting sperm for ICSI - IMSI Allan Pacey University of Sheffield Sheffield Teaching Hospitals.
ART FOR PCOS-DIFFICULTIES AND SOLUTIONS Dr. Bulent Urman American Hospital, ISTANBUL Assisted Reproduction Unit Koç University, Faculty of Medicine Department.
Ri-Cheng Chian, Ph.D. McGill Reproductive Center McGill University Health Center Department of Obstetrics and Gynecology McGill University, Montreal Canada.
In-vitro maturation: patient selection and results Aygul Demirol Assoc Prof, Medical Director GURGAN CLINIC IVF Center, Ankara-Turkey.
(Miz Medi Hospital) Jung-Hyun Cho, M.D. (Miz Medi Hospital) Minimal Ovarian Stimulation.
In Vitro Fertilization by: Nicholas Fowler and Rebecca Kaldahl.
Problems with the In Vitro Fertilisation Treatment of Heterosexual Couples Health Law and Bioethics Georgi Avramov, Student Number: , Erasmus + Student.
IVF TROUBLESHOOTING ( Clinical Perspective) Malvin Emeraldi M. Luky, Dianing ASR,Muchsin J Family Fertility Center, RSIA Family Fatmawaty Hospital Jakarta,
Konstantin Y. Boyarsky1,2, MD, PhD
Topic- Test Tube Baby Group members: Mohd. Hasnanin Nizam Thakur Rifaquat Ahmed Rafiul Islam Adib Course Teacher: Dr. Aparna Islam Associate Professor.
Welcome.
Too slow? we don’t think so. Outcomes relative to embryo development
Ovarian Hyper Stimulation Syndrome (OHSS)
Preimplantation Genetic Diagnosis (PGD)
The next (re)generation of ovarian biology and fertility in women: is current science tomorrow's practice?  Dori C. Woods, Ph.D., Jonathan L. Tilly, Ph.D. 
Blastocyst versus cleaved embryo transfer: do we have enough evidence?
In Vitro Fertilization and Prenatal Diagnosis DENIZ ESER MERVE GÜLMEZ SELEN İREM GORALI
APPLICATION OF VITRIFICATION IN GENETIC ART
The International Glossary on Infertility and Fertility Care, 2017
Presentation transcript:

The Women’s Clinic 婦產科中心 Current Criticism on IVM Treatment Dr. Milton Leong MDCM DSc (McGill) Director, IVF Center, Hong Kong Sanatorium & Hospital Specialist in Reproductive Medicine Adjunct Professor, OBS-GYN, McGill University 1

The Women’s Clinic 婦產科中心 Current Criticism of IVM Lower fertilization rate Lower pregnancy & implantation rates Higher pregnancy loss Inadequate neonatal and postnatal data Possible genetic and epigenetic changes

The Women’s Clinic 婦產科中心 Current Criticism of IVM Inconsistent pregnancy rates Inconsistent clinical details regarding timing, endometrium, EC techniques Inconsistent laboratory details regarding EC, culture system and culture techniques Inertia from IVF success vs “experimentation”

The Women’s Clinic 婦產科中心 Current Status of IVM Like IVF 25 years ago, IVM is a treatment tool waiting to be universally applicable. At the moment, there is some sort of alchemy bias. There are also unresolved issues, like IVF then, that needs to be clarified.

The Women’s Clinic 婦產科中心 Current Status of IVM IVM is a CONCEPT IVM is a laboratory technique, not a stand alone treatment modality IVM is a method of preparing oocytes so IVF can be carried out IVF/M have its advantages over conventional IVF in some patients IVM can enable IVF to be performed when otherwise it is impossible

The Women’s Clinic 婦產科中心 Current Status of IVM Similar to IVF in 80’s, issues regarding IVM: Technical - timing of EC aspiration technique drugs to use Laboratory - culture system Outcome - now there is IVF to compare Safety - baby registry long term genetic changes

The Women’s Clinic 婦產科中心 Progress in IVM  Edwards 1965 : 1st in vitro matured oocyte  Veeck 1983 : 1st IVM pregnancy from an ovum derived from a  stimulated cycle  Cha et al : the first pregnancy from in-vitro matured oocytes derived from a caesarean section donor  Trounson et al. 1994: IVM in women with PCOS  improvements in culture condition and transfer techniques have demonstrated that IVM is an effective treatment for women with PCO or PCOS.  In general, clinical pregnancy and implantation rates for infertile women with PCO or PCOS have reached approximately 30-35% and 10-15%, respectively, (Chian et al., 2004). 

The Women’s Clinic 婦產科中心 Advantages of IVM No/minimal stimulation: less OHSS less long term effect safety factor – cancer patients Flexible start time, no preparation Cancer patients no theoretical and actual risk (especially breast ca) can treat anytime

The Women’s Clinic 婦產科中心 Indications for IVFM treatment Polycystic ovaries (PCO) or polycystic ovary syndrome (PCOS) (primary); Hyper responders for gonadotropin stimulation (alternative); Delayed responders for gonadotropin stimulation (alternative); 9

The Women’s Clinic 婦產科中心 PCOS and IVF Pregnancies were comparable to non- PCOS patients Lowered fertilization rate Increased miscarriage rate FSH requirement leads to under or over response Higher cancellation rate Much higher chance of OHSS

The Women’s Clinic 婦產科中心 PCOS, OHSS and IVF Risk up 5-30 fold (6-30%) Estradiol >3000pg/ml # Follicles >20

The Women’s Clinic 婦產科中心 OHSS in PCOS Undergoing IVF Preventive Measures: Pre-treat with laparoscopic drilling Use GnRH-ant then GnRH-a to trigger Metformin (as short as 28 days) No Transfer, Cryopreservation Early Aspiration of Follicles - 2 operations Conversion to IVM IVM with and/or without stimulation

The Women’s Clinic 婦產科中心 GnRHa v.s. HCG in IVF-IVF used in PCOS 300 ųg Buserelin vs unit HCG Maturation ratesame(±50%) Fertilization ratesame85% Pregnancy ratesame41% OHSS rate< 1% A. Fukuda et al, Fertility and Sterility

The Women’s Clinic 婦產科中心 IVM/IVF vs IVF for PCOS Child TJ, et al,2002

The Women’s Clinic 婦產科中心 IVM-IVF in POS 210 cycles 1883 oocytes56% maturation 83% fertilization Pregnancy rate31% fresh 32% frozen-thawed 50/56 pregnancies delivered Miscarriage11% A. Fukuda et al, Fertility & Sterility

The Women’s Clinic 婦產科中心 McGill IVM results by age group (own oocytes only – patients with PCOS) Age(years) Implantation rate per embryo Clinical pregnancy rate per cycle started Live birth rate per cycle started <3514.4%34.8%20.0% %20.0%20.0% %20.0%10.0% 16

The Women’s Clinic 婦產科中心 Obstetric and perinatal outcomes of the IVM pregnancies

The Women’s Clinic 婦產科中心 Updated IVM success rates Clinical pregnancy rate 30-35% per ET; Implantation rate 9-15% per ET; More than 1,000 healthy live births; 18

The Women’s Clinic 婦產科中心 Pregnancy Outcome in IVM Malformation: –Cha, Fertil. Steril ,3% major malformation rate Later neuromotor development: –Soderstrom-Anttila, Hum. Reprod ))) Minor developmental delay at first year ))) No Difference in the second year

20

The Women’s Clinic 婦產科中心 Outcome of IVM, IVF, ICSI and normal pregnancies obstetrical and perinatal outcome of 432 babies (55 IVM, 217 IVF, 160 ICSI) compared with 1,296 age-matched spontaneous pregnancies (controls) delivered at a single hospital (MUHC) Buckett et al. Obstet Gynecol 2007; 110:885-91

The Women’s Clinic 婦產科中心 Perinatal outcome IVMIVFICSIControlsp-value Twin pregnancy rate12.0%16.0%14.0%1.3%p<0.001 Triplet pregnancy rate4.0%2.0%3.0%0p<0.001 Mean birthweight (g)2,8122,8262,8013,289p<0.001 Mean gestational age (wks) p<0.001 Mean Apgar scores at 1 min8888n/s Mean Apgar scores at 5 min9999n/s Mean cord pH n/s

The Women’s Clinic 婦產科中心 Congenital abnormalities following IVM (n=55) Major malformations2 ompalocele small ventricuoloseptal defect 1111 Minor malformations3 patent ductus arteriosus1 congenital hip dislocation2

The Women’s Clinic 婦產科中心 Relative risk for any congenital abnormality compared with controls RR95% CI IVM – 3.25 IVF – 1.90 ICSI – 2.68

The Women’s Clinic 婦產科中心 Pregnancy Outcome in IVM Mikkelsen et al. (2005) IVM babies –2 twins –1 NT Normal karyotype –2 preterm deliveries –1 stillbirth (42 weeks) –1 chromozomal abnormality

The Women’s Clinic 婦產科中心 Worldwide IVM babies born (2007) Korea455 Taiwan20 Colombia7 Canada131 Finland52 Turkey8 China58 Japan51 Vietnam42 Hong Kong18 Denmark34 Italy56 UK8 Total930

The Women’s Clinic 婦產科中心 Drawbacks in IVM – Lower development competence – Lower blastocysts formation – Lower implantation rate – Lower pregnancy rate – Higher miscarriage rate But, where is the beef? 27

The Women’s Clinic 婦產科中心 Development Competence of Oocytes 1.Nuclear maturation – progression to Meta phase II stage. 2.Cytoplasmic maturation – coordinated arrangement of proteins, organelles. Gosden R et al, Bioessays 1997 Nogueira D et al, Fertil Steril

The Women’s Clinic 婦產科中心 Development Competence of Oocytes 1.IVM results in asynchronous nuclear vs. cytoplasmic maturation 2.IVM (mouse oocytes) showed different spindle morphology when assessed with immuncytologic staining. Combelles CM et al, Human Reprod 2002 Sanfins A et al, Biol Reprod

The Women’s Clinic 婦產科中心 Results of the spindle and chromosome analysis in both experimental groups. No.(%) of oocytes with Oocyte GroupSpindle configurationChromosome configuration NormalAbnormalNormalAbnormal Oocytes matured in vitro27(56.3)21(43.7) a 32(66.7) 16(33.3) a (n = 48) Oocytes matured in vivo19(86.4)3 (13.6)20(90.9) 2(9.1) (n = 22) a P<.05 vs. oocytes matured In vivo. Li. Spindle and chromosome configurations of human oocytes. Fertil Steril

The Women’s Clinic 婦產科中心 Does size matter – In vivo matured oocytes > immature. – Maturation rate (IVM) related to diameter of oocytes. – Zona thickness, total oocytes + zona diameter has no correlation. Cavilla JL et al, Human Reprod

The Women’s Clinic 婦產科中心 Outcome of IVM – In mouse, in vitro vs. in vivo maturation. – In vitro: a) established optimized culture fluid b) no amino acid culture fluid –Comparing life span, and variety of physiological and psychological tests. –No difference between in vitro or in vivo life span or behavior. –In culture fluid a) reduction in cardiac output and pulse rate. Eppig JJ et al, Human Reprod

The Women’s Clinic 婦產科中心 Outcome of IVM 21 children IVM vs. non IVM, age 2-5 PE – neurological examination and developmental (Bayley Scales) Findings: Normal Karyotype, Normal PE Mean Mental Developmental Index Score 92.7% vs. 97.2%, Mean Psychomotor Development Index Scores 96.7% vs. 96.2%. Conclusion: No developmental delay in infancy and early childhood Shu-chi M et al, Early Hum Dev

The Women’s Clinic 婦產科中心 Outcome in IVM 46 children assessed at 6, 12, 24 months Muenchener Funktionelle Entwicklungs Diagnostik and Bayley Scales 6 mthsNormal 12 mths19% IVM expressed minor developmental problem 1/43 had optic glioma 24 mthsNormal development Suikkari M et al, Human Repro

The Women’s Clinic 婦產科中心 Outcome of IVM IVM vs. IVF vs. ICSI N = 1581IVMIVFICSI Biochemical loss17.5%17%18%ND Clinical miscarriage rate 25.3%15.7%12.6%SD Ectopic preg.1%2.3%1.8%ND Late foetal loss1%2.7%2.9%ND PCOS24.5%22.2%ND 35 Buckett WM et al, Fertil Steril 2008

The Women’s Clinic 婦產科中心 IVM outcome High miscarriage rate may be due to other causes (endometrium?) because cytogenetic and DNA fragmentation analysis of the aborted embryos were not different from routine IVF. Benkhalifa Meta, Reprod Biomed Online

The Women’s Clinic 婦產科中心 Genetics in IVM Methylation of the KCNQ1OT1 gene in vitro matured oocytes methylate DNA the same as GV and mature genes. At 28 hours of culture, however, GV and MI oocytes from natural cycles significantly methylate more than those from stimulated cycles. ?Hyperstimulation recruits too young follicles Khoueiry R, J Med Genet

The Women’s Clinic 婦產科中心 Genetics in IVM No difference in meiotic spindle organization, chromosome alignment and aneuploidy (mouse oocytes) Xu L et al, Syst Biol Reprod Med

The Women’s Clinic 婦產科中心 Effect of IVM on Genes 39

The Women’s Clinic 婦產科中心 Genes and IVM Rhesus Monkey oocytes IVM vs. VVM Only 56 mRNA’s differentially expressed. These are related to cell homeostasis, cell-cell interactions, cell adhesion, mRNA stability and translation. Over expression of maternal genes. IVM oocytes can be very close to VVM oocytes but interruption of normal oocyte-somatic cell interaction may disturb full developmental competence. Lee YS et al, Physiol Genomics

The Women’s Clinic 婦產科中心 Genes and IVM IVM, then examine GV, MI, MII oocytes, using H19. Differentially methylated region GV Unmethylated MIArrested – altered methylation pattern MII15/20 normal unmethylated pattern 5/20 methylated pattern Risk of epigenetic changes so safety of IVM should be assessed. Borghol N et al, Genomics

The Women’s Clinic 婦產科中心 Genes in IVM Although in vivo maturated an in vitro maturated oocytes has very similar gene expression, the major difference is in persistence of immature genes. IVM oocytes differs in gene expression related to cytoplasmic function and cellular storage and homeostasis. Well D et al, Am J Obstet Gynecol

The Women’s Clinic 婦產科中心 IVM successes – PCOS patients – Natural cycle IVF/M – Birth after vitrification – Repeated successful pregnancies in same patients – Birth after preservation of oocytes for cancer patients McGill Reproductive Centre 43

The Women’s Clinic 婦產科中心 IVM is efficient infertility treatment, especially for patients with PCO/PCOS; IVM provides an alternative for some patients during ovarian stimulation cycles. Conclusions 44

The Women’s Clinic 婦產科中心 Conclusions IVM simplifies treatment, reduces costs and eliminates OHSS IVM successful in women with high AFC hCG increases final number of MII oocytes and rate of maturation IVM may be helpful in women with repeated poor embryo quality in previous IVF cycles for no obvious reason, or repeated poor responders to ovarian stimulation

The Women’s Clinic 婦產科中心 Conclusions IVM produces CPR/C of 35%, and up to 48% in selected cases, in women up to 35. obstetric and perinatal outcomes of IVM pregnancies comparable with IVF and ICSI IVM may be useful for oocyte donation or PGD IVM may offer a chance for fertility preservation to young women with cancer and undergoing cytotoxic treatment. IVM may not replace standard IVF but appears to play increasingly important role in ART

The Women’s Clinic 婦產科中心 Current Status of IVM An established treatment for PCO/PCOS In experienced hands closing on IVF Needs registry outcome and follow up Some animal data regarding genetic changes May be epigenetic changes All can be solved by proper practice and follow up and large data collection as in REGISTRY